Finance

Beta
Lists
OTLC:OTCMKTS
Oncotelic Therapeutics Inc
$0.048
-5.00%
(-0.0025) 1D
Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLC...
Open
$0.05
High
$0.05
Low
$0.05
Mkt. cap
21.11M
Avg. vol.
323.22K
Volume
93.01K
P/E ratio
0.09
52-wk high
$0.11
52-wk low
$0.02
EPS
$0.55
Beta
-0.33
Shares outstanding
444.50M
No. of employees
41
Open
$0.05
High
$0.05
Low
$0.05
Mkt. cap
21.11M
Avg. vol.
323.22K
Volume
93.01K
P/E ratio
0.09
52-wk high
$0.11
52-wk low
$0.02
EPS
$0.55
Beta
-0.33
Shares outstanding
444.50M
No. of employees
41
News stories
From sources across the web
About Oncotelic Therapeutics Inc
CEO-
Employees41
Founded1988
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
297.00
426.00
3.34K
795.00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65.67K
490.55K
2.33M
1.85M
Operating expense
65.97K
490.97K
2.33M
1.85M
Total operating expenses
65.97K
490.97K
2.33M
1.85M
Operating income
-65.97K
-490.97K
-2.33M
-1.85M
Other non operating income
484.20K
-392.06K
326.43K
-90.08K
EBT including unusual items
210.45K
-1.11M
361.84M
-2.24M
EBT excluding unusual items
210.45K
-1.11M
-2.24M
-2.24M
Income tax expense
-
-
111.55M
-
Effective tax rate
-
-
30.83%
-
Other operating expenses
-
-
-
-
Net income
277.86K
-1.05M
250.35M
-2.19M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-207.78K
-231.34K
-242.57K
-295.81K
Net interest expenses
-207.78K
-231.34K
-242.57K
-295.81K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more